Related Experiment Video
Updated: May 14, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
Published on: May 27, 2016
Natural Products as Modulators of ABC Transporters in Breast Cancer
Yoganishalini Sagadevan1, Reyhaneh Farghadani1,2, Ammu K Radhakrishnan1
1Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Sunway City, Malaysia.
Abstract:
Breast cancer remains a significant global health challenge, with high incidence and mortality rates despite advancements in early detection and treatment. Multidrug resistance (MDR), particularly in aggressive subtypes like triple-negative breast cancer (TNBC), continues to hinder effective therapy. MDR is primarily driven by the overexpression of ATP-binding cassette (ABC) transporters such as P-gp, BCRP, and MRP1. ABC transporters actively efflux chemotherapeutic agents, reducing their efficacy and complicating treatment outcomes. This narrative review explores the potential of natural products to modulate ABC transporters as a strategy to mitigate MDR in breast cancer. A literature search was conducted across Ovid Medline, PubMed, Scopus, Embase, Web of Science, and EBSCOhost. Articles underwent a two-stage screening process (title and abstract and full text), with additional manual searches of reference lists. The results show that natural products derived from plants can inhibit ABC transporters through suppression of protein expression, downregulation of mRNA expression, and inhibition of drug efflux functions. Additionally, they target indirect regulatory pathways, such as NF-κB, YB-1, PI3K/Akt, and ATPase activity, further contributing to the reversal of MDR. These compounds work synergistically with chemotherapeutic agents like doxorubicin and paclitaxel to enhance drug retention and efficacy while reducing toxicity. This multifaceted approach highlights the potential of natural products as valuable adjunct therapies in breast cancer treatment, offering new strategies to overcome drug resistance and improve patient outcomes.
Insights
Natural products can overcome breast cancer multidrug resistance (MDR) by inhibiting ATP-binding cassette (ABC) transporters. These compounds enhance chemotherapy efficacy and reduce toxicity, offering new therapeutic strategies for aggressive breast cancer subtypes.
Area of Science:
- Oncology
- Pharmacology
- Natural Product Chemistry
Background:
- Breast cancer, especially triple-negative breast cancer (TNBC), faces treatment challenges due to multidrug resistance (MDR).
- ATP-binding cassette (ABC) transporters (e.g., P-gp, BCRP, MRP1) are key drivers of MDR by actively exporting chemotherapeutic drugs.
- This efflux reduces intracellular drug concentrations, leading to treatment failure and poor patient outcomes.
Purpose of the Study:
- To review the potential of natural products in overcoming MDR in breast cancer by targeting ABC transporters.
- To explore the mechanisms by which natural products modulate ABC transporter activity and related pathways.
- To assess the synergistic effects of natural products with conventional chemotherapy in breast cancer treatment.
Main Methods:
- A comprehensive literature search was performed across major scientific databases (Ovid Medline, PubMed, Scopus, Embase, Web of Science, EBSCOhost).
- Articles were screened using a two-stage process (title/abstract and full text review), supplemented by reference list searches.
- The review synthesized findings on natural product interactions with ABC transporters and MDR-related pathways.
Main Results:
- Natural products inhibit ABC transporters via suppression of protein and mRNA expression, and direct inhibition of drug efflux.
- These compounds modulate indirect regulatory pathways, including NF-κB, YB-1, PI3K/Akt signaling, and ATPase activity.
- Natural products demonstrate synergistic effects with chemotherapeutics like doxorubicin and paclitaxel, enhancing drug efficacy and reducing toxicity.
Conclusions:
- Natural products show significant promise as adjunct therapies to reverse MDR in breast cancer.
- Targeting ABC transporters with natural compounds offers a novel strategy to improve treatment outcomes for resistant breast cancer.
- Further research into these natural agents could lead to improved therapeutic regimens and better patient survival rates.
Related Concept Videos
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
